Peripheral T-cell Lymphoma  >>  Istodax (romidepsin) 
Welcome,         Profile    Billing    Logout  

6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Istodax (romidepsin) / Astellas, BMS
RV-CL-PTCL-PI-003974, NCT02232516: Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Active, not recruiting
2
30
US
romidepsin, FK228, FR901228, Istodax, lenalidomide, CC-5013, IMiD-1, Revlimid, laboratory biomarker analysis
Northwestern University, Celgene, National Cancer Institute (NCI)
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IA Mycosis Fungoides/Sezary Syndrome, Stage IB Mycosis Fungoides/Sezary Syndrome, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IIA Mycosis Fungoides/Sezary Syndrome, Stage IIB Mycosis Fungoides/Sezary Syndrome, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IIIA Mycosis Fungoides/Sezary Syndrome, Stage IIIB Mycosis Fungoides/Sezary Syndrome, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IVA Mycosis Fungoides/Sezary Syndrome, Stage IVB Mycosis Fungoides/Sezary Syndrome
08/20
08/24
NCT04747236: Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL

Recruiting
2
50
US
Azacytidine, Vidaza, Romidepsin, Istodax, Belinostat, Beleodaq, Pralatrexate, Folotyn, Gemcitabine, Gemzar
University of Virginia, Celgene
PTCL
12/26
06/28
2013-005179-41: ROMIDEPSIN IN COMBINATION WITH CHOEP AS FIRST LINE TREATMENT BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION IN YOUNG PATIENTS WITH NODAL PERIPHERAL T-CELL LYMPHOMAS: A PHASE I-II STUDY. ROMIDEPSINA IN COMBINAZIONE CON CHOEP COME TERAPIA DI PRIMA LINEA IN PREPARAZIONE AL TRAPIANTO DI CELLULE STAMINALI EMOPOIETICHE NEI PAZIENTI GIOVANI CON LINFOMA A CELLULE T PERIFERICHE A LOCALIZZAZIONE NODALE: STUDIO DI FASE I-II

Not yet recruiting
1/2
122
Europe
Romidepsin, FK228, Powder and solvent for solution for infusion, Solution for infusion, Powder and solvent for solution for injection, Solution for injection, Powder and solution for solution for injection, Tablet, ISTODAX
Fondazione Italiana Linfomi ONLUS (FIL-ONLUS), CELGENE Corporation
Newly diagnosed patients with Peripheral T-cell lymphomas including: Peripheral T-cell lymphomas not otherwise specified (PTCL-NOS), Angioimmunoblastic T-cell lymphoma (AITL) and ALK– Anaplastic large-cell lymphoma (ALCL). Pazienti di nuova diagnosi con linfoma a cellule T periferiche ovvero: Linfoma a Cellule T Non Altrimenti Specificato (PTCL-NOS), Linfoma a Cellule T Angioimmunoblastico (AITL) Linfoma Anaplastico a Grandi Cellule ALK negativo (ALCL)., Newly diagnosed patients with Peripheral T-cell lymphomas. Pazienti di nuova diagnosi con linfoma a cellule T periferiche., Diseases [C] - Blood and lymphatic diseases [C15]
 
 
NCT03547700: Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Active, not recruiting
1/2
11
US
Romidepsin, Istodax, Ixazomib, Ninlaro
Ryan Wilcox, University of Michigan Rogel Cancer Center, Takeda
Lymphoma, T-Cell, Peripheral
03/21
07/21
NCT02512497: Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Recruiting
1
10
US
Romidepsin, Istodax, Depsipeptide, FK228, Busulfan, Busulfex, Myleran, Fludarabine, Fludarabine Phosphate, Fludara, Stem Cell Transplant, Thymoglobulin, ATG, Rabbit Antithymocyte Globulin, Rabbit Antilymphocyte Globulin, Rabbit ATG, rATG
Ohio State University Comprehensive Cancer Center, Celgene Corporation
Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia, T-Lymphoblastic Leukemia/Lymphoma, Peripheral T-Cell Lymphoma
12/22
12/22
NCT03742921: ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

Completed
N/A
150
Japan
Istodax
Celgene
Lymphoma, T-Cell, Peripheral
10/23
10/23

Download Options